Dr. Tripathy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-563-0903
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1989 - 1991
Duke University HospitalResidency, Internal Medicine, 1985 - 1989
Duke University School of MedicineClass of 1985
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
MS State Medical License 2023 - 2025
OK State Medical License 2020 - 2025
TN State Medical License 2023 - 2025
TX State Medical License 2002 - 2025
WA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006, 2010-2014
- Top Doctors:LA Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2007, 2009-2013
- Join now to see all
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer Start of enrollment: 2012 May 16
- Core Biopsies for Establishing a Breast Tumor Tissue Repository Start of enrollment: 2013 Nov 14
- Join now to see all
Publications & Presentations
PubMed
- 196 citationsMRI Measurements of Breast Tumor Volume Predict Response to Neoadjuvant Chemotherapy and Recurrence-Free SurvivalSavannah C. Partridge, Jessica Gibbs, Ying Lu, Laura J. Esserman, Debasish Tripathy
AJR. American Journal of Roentgenology. 2005-06-01 - 312 citationsPathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657Laura J. Esserman, Donald A. Berry, Angela DeMichele, Lisa A. Carey, Sarah E. Davis
Journal of Clinical Oncology. 2012-09-10 - 2117 citationsMultinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progr...Melody A. Cobleigh, Charles L. Vogel, Debasish Tripathy, Nicholas J. Robert, Susy Scholl
Journal of Clinical Oncology. 1999-09-01
Press Mentions
Giving HRT to Breast Cancer Survivors DOES NOT Raise Risk of Recurrence, Study SuggestsJuly 20th, 2022- New Treatments Changing the Lives of People with Breast Cancer, and More Promise Lies AheadOctober 8th, 2021
Physicians’ Education Resource® Presents Three Satellite Symposia at the 36th Annual Miami Breast Cancer Conference®February 25th, 2019- Join now to see all
Grant Support
- Expression Analysis Of ERBB Receptor Targeted TherapiesNational Cancer Institute2001–2002
- Core--Clinical CoreNational Cancer Institute1995–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
